Drug intelligence / Profile preview

DC-006

Development stage
Phase 2
Lead developer
Osaka University
Modality
Dendritic Cell Vaccines → Immune Effector Cells → Other Cell Types → Cell Therapies, Vaccines & Immunotherapeutics
Administration
Intradermal
01

Overview

**DC-006** is an investigational, personalized autologous dendritic-cell cancer vaccine developed for recurrent platinum-sensitive epithelial ovarian cancer. Patient-derived dendritic cells are transfected with mRNA from amplified ovarian cancer stem cells together with mRNAs encoding human telomerase reverse transcriptase and survivin. The vaccine is intended to present these tumor-associated antigens to the immune system and induce cytotoxic T-cell responses against ovarian cancer cells expressing hTERT, survivin, and ovarian cancer stem-cell antigens.

Other names
DC-006 vaccineDC006 vaccineDC 006 vaccineovarian cancer stem cell/hTERT/survivin mRNAs-loaded autologous dendritic cell vaccine
02

Targets

EGFR T790M (Epidermal growth factor receptor T790M mutant)DDR1 (Discoidin domain receptor 1)

Beyond the preview

Go deeper on DC-006.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DC-006.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call